vs

Side-by-side financial comparison of IMMUCELL CORP (ICCC) and Red Cat Holdings, Inc. (RCAT). Click either name above to swap in a different company.

Red Cat Holdings, Inc. is the larger business by last-quarter revenue ($9.6M vs $5.5M, roughly 1.8× IMMUCELL CORP). IMMUCELL CORP runs the higher net margin — -2.5% vs -166.0%, a 163.5% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs -8.4%). IMMUCELL CORP produced more free cash flow last quarter ($-1.8M vs $-24.5M).

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

ICCC vs RCAT — Head-to-Head

Bigger by revenue
RCAT
RCAT
1.8× larger
RCAT
$9.6M
$5.5M
ICCC
Growing faster (revenue YoY)
RCAT
RCAT
+996.6% gap
RCAT
988.2%
-8.4%
ICCC
Higher net margin
ICCC
ICCC
163.5% more per $
ICCC
-2.5%
-166.0%
RCAT
More free cash flow
ICCC
ICCC
$22.7M more FCF
ICCC
$-1.8M
$-24.5M
RCAT

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
ICCC
ICCC
RCAT
RCAT
Revenue
$5.5M
$9.6M
Net Profit
$-139.7K
$-16.0M
Gross Margin
42.9%
6.6%
Operating Margin
0.4%
-181.7%
Net Margin
-2.5%
-166.0%
Revenue YoY
-8.4%
988.2%
Net Profit YoY
80.1%
-29.0%
EPS (diluted)
$-0.02
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ICCC
ICCC
RCAT
RCAT
Q3 25
$5.5M
$9.6M
Q2 25
$6.4M
Q1 25
$8.1M
$1.6M
Q4 24
$7.8M
$0
Q3 24
$6.0M
Q2 24
$5.5M
Q1 24
$7.3M
$5.8M
Q4 23
$5.1M
Net Profit
ICCC
ICCC
RCAT
RCAT
Q3 25
$-139.7K
$-16.0M
Q2 25
$501.9K
Q1 25
$1.4M
$-23.1M
Q4 24
$-13.3M
Q3 24
$-701.7K
Q2 24
$-1.5M
Q1 24
$-437.9K
$-5.5M
Q4 23
Gross Margin
ICCC
ICCC
RCAT
RCAT
Q3 25
42.9%
6.6%
Q2 25
43.7%
Q1 25
41.6%
-52.2%
Q4 24
36.5%
Q3 24
26.3%
Q2 24
22.5%
Q1 24
31.6%
18.8%
Q4 23
24.7%
Operating Margin
ICCC
ICCC
RCAT
RCAT
Q3 25
0.4%
-181.7%
Q2 25
8.8%
Q1 25
13.9%
-765.7%
Q4 24
8.0%
Q3 24
-9.6%
Q2 24
-25.3%
Q1 24
-4.1%
-76.0%
Q4 23
-19.7%
Net Margin
ICCC
ICCC
RCAT
RCAT
Q3 25
-2.5%
-166.0%
Q2 25
7.8%
Q1 25
17.9%
-1418.9%
Q4 24
Q3 24
-11.7%
Q2 24
-28.0%
Q1 24
-6.0%
-93.9%
Q4 23
EPS (diluted)
ICCC
ICCC
RCAT
RCAT
Q3 25
$-0.02
$-0.16
Q2 25
$0.06
Q1 25
$0.16
$-0.27
Q4 24
$0.09
Q3 24
$-0.09
Q2 24
$-0.20
Q1 24
$-0.06
Q4 23
$-0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ICCC
ICCC
RCAT
RCAT
Cash + ST InvestmentsLiquidity on hand
$3.9M
Total DebtLower is stronger
$9.5M
Stockholders' EquityBook value
$29.8M
$253.3M
Total Assets
$45.7M
$286.0M
Debt / EquityLower = less leverage
0.32×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ICCC
ICCC
RCAT
RCAT
Q3 25
$3.9M
Q2 25
Q1 25
Q4 24
$3.8M
Q3 24
Q2 24
$1.3M
Q1 24
$960.3K
Q4 23
$978.7K
Total Debt
ICCC
ICCC
RCAT
RCAT
Q3 25
$9.5M
Q2 25
Q1 25
$8.7M
Q4 24
$9.0M
Q3 24
$9.4M
Q2 24
$9.8M
Q1 24
$10.2M
Q4 23
$10.5M
Stockholders' Equity
ICCC
ICCC
RCAT
RCAT
Q3 25
$29.8M
$253.3M
Q2 25
$29.9M
Q1 25
$29.0M
$28.9M
Q4 24
$27.5M
$27.0M
Q3 24
$26.4M
Q2 24
$23.5M
Q1 24
$24.6M
$49.6M
Q4 23
$25.0M
Total Assets
ICCC
ICCC
RCAT
RCAT
Q3 25
$45.7M
$286.0M
Q2 25
$46.7M
Q1 25
$45.6M
$59.7M
Q4 24
$45.1M
$51.1M
Q3 24
$44.4M
Q2 24
$41.9M
Q1 24
$43.1M
$55.3M
Q4 23
$43.8M
Debt / Equity
ICCC
ICCC
RCAT
RCAT
Q3 25
0.32×
Q2 25
Q1 25
0.30×
Q4 24
0.33×
Q3 24
0.36×
Q2 24
0.42×
Q1 24
0.41×
Q4 23
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ICCC
ICCC
RCAT
RCAT
Operating Cash FlowLast quarter
$-1.2M
$-23.9M
Free Cash FlowOCF − Capex
$-1.8M
$-24.5M
FCF MarginFCF / Revenue
-32.3%
-254.2%
Capex IntensityCapex / Revenue
10.8%
6.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$715.4K
$-55.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ICCC
ICCC
RCAT
RCAT
Q3 25
$-1.2M
$-23.9M
Q2 25
$1.6M
Q1 25
$1.6M
$-15.9M
Q4 24
$-3.1K
$-10.1M
Q3 24
$-639.3K
Q2 24
$581.8K
Q1 24
$418.5K
$-4.1M
Q4 23
$-723.1K
Free Cash Flow
ICCC
ICCC
RCAT
RCAT
Q3 25
$-1.8M
$-24.5M
Q2 25
$1.4M
Q1 25
$1.2M
$-16.2M
Q4 24
$-199.3K
$-10.2M
Q3 24
$-727.7K
Q2 24
$471.0K
Q1 24
$348.1K
$-4.2M
Q4 23
$-804.4K
FCF Margin
ICCC
ICCC
RCAT
RCAT
Q3 25
-32.3%
-254.2%
Q2 25
22.4%
Q1 25
15.4%
-992.9%
Q4 24
-2.6%
Q3 24
-12.1%
Q2 24
8.6%
Q1 24
4.8%
-71.1%
Q4 23
-15.8%
Capex Intensity
ICCC
ICCC
RCAT
RCAT
Q3 25
10.8%
6.9%
Q2 25
2.4%
Q1 25
4.1%
16.8%
Q4 24
2.5%
Q3 24
1.5%
Q2 24
2.0%
Q1 24
1.0%
0.8%
Q4 23
1.6%
Cash Conversion
ICCC
ICCC
RCAT
RCAT
Q3 25
Q2 25
3.19×
Q1 25
1.09×
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ICCC
ICCC

Segment breakdown not available.

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

Related Comparisons